Skip to main content
Top
Gepubliceerd in:

01-12-2003 | Artikelen

Osteoporose op de kinderleeftijd

Auteurs: Dr. I. M. van der Sluis, Dr. S. M. P. F. de Muinck Keizer-Schrama

Gepubliceerd in: Tijdschrift voor Kindergeneeskunde | Uitgave 1/2003

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Osteoporose wordt gekenmerkt door verminderde botdichtheid, een verslechtering van de microarchitectuur van het bot en een verhoogd fractuurrisico. De botdichtheid op oudere leeftijd wordt onder andere bepaald door de piekbotmassa die wordt bereikt op jongvolwassen leeftijd. Een verminderde botdichtheid is geassocieerd met een verhoogd fractuurrisico bij volwassenen en kinderen. Idiopathische juveniele osteoporose en osteogenesis imperfecta zijn voorbeelden van primaire osteoporose. Op de kinderleeftijd is osteoporose echter vaker het gevolg van een chronische ziekte of de behandeling van die ziekte. Preventie en behandeling van osteoporose met bijvoorbeeld calcium en vitamine-D-suppletie, bisfosfonaten, groeihormoon en de effecten van trainingsprogramma's behoeven nadere evaluatie.
Literatuur
go back to reference Cummings SR, Black DM, Nevitt MN, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341:72-5.CrossRefPubMed Cummings SR, Black DM, Nevitt MN, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341:72-5.CrossRefPubMed
go back to reference Goulding A, Jones IE, Taylor RW, et al. More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000;15:2011-8.CrossRefPubMed Goulding A, Jones IE, Taylor RW, et al. More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000;15:2011-8.CrossRefPubMed
go back to reference Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 1996;11(12):1841-9.CrossRefPubMed Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 1996;11(12):1841-9.CrossRefPubMed
go back to reference Gong G, Stern HS, Cheng SC, et al. The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporos Int 1999;9(1):55-64.CrossRefPubMed Gong G, Stern HS, Cheng SC, et al. The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporos Int 1999;9(1):55-64.CrossRefPubMed
go back to reference Mann V, Hobson EE, Li B, et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 2001;107(7):899-907.CrossRefPubMed Mann V, Hobson EE, Li B, et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 2001;107(7):899-907.CrossRefPubMed
go back to reference Sluis IM van der. Children's bone health [thesis]. Rotterdam: Erasmus MC; 2002. Sluis IM van der. Children's bone health [thesis]. Rotterdam: Erasmus MC; 2002.
go back to reference Sluis IM van der, Muinck Keizer-Schrama S de, Pols HAP, et al. Collagen IA1 polymorphism is associated with bone characteristics in Caucasian children and young adults. Calcif Tissue Int 2002;71:393-9.CrossRefPubMed Sluis IM van der, Muinck Keizer-Schrama S de, Pols HAP, et al. Collagen IA1 polymorphism is associated with bone characteristics in Caucasian children and young adults. Calcif Tissue Int 2002;71:393-9.CrossRefPubMed
go back to reference Boot AM, Ridder MAJ de, Pols HAP, et al. Bone mineral density in children and adolescents: Relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab 1997;82:57-62.CrossRefPubMed Boot AM, Ridder MAJ de, Pols HAP, et al. Bone mineral density in children and adolescents: Relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab 1997;82:57-62.CrossRefPubMed
go back to reference Sluis IM van der, Ridder MAJ de, Boot AM, et al. Reference data for bone density and body composition measured with dual energy X ray absorptiometry in white children and young adults. Arch Dis Child 2002:87:341-7.CrossRefPubMed Sluis IM van der, Ridder MAJ de, Boot AM, et al. Reference data for bone density and body composition measured with dual energy X ray absorptiometry in white children and young adults. Arch Dis Child 2002:87:341-7.CrossRefPubMed
go back to reference Coeverden SC van, Netelenbos JC, Roos JC, et al. Reference values for bone mass in Dutch white pubertal children and their relation to pubertal maturation characteristics. Ned Tijdschr Geneeskd 2001;145(38):1851-6.PubMed Coeverden SC van, Netelenbos JC, Roos JC, et al. Reference values for bone mass in Dutch white pubertal children and their relation to pubertal maturation characteristics. Ned Tijdschr Geneeskd 2001;145(38):1851-6.PubMed
go back to reference Kröger HPJ, Vainio P, Nieminen J, et al. Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone 1995;17:157-9.CrossRefPubMed Kröger HPJ, Vainio P, Nieminen J, et al. Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone 1995;17:157-9.CrossRefPubMed
go back to reference Sluis IM van der, Hop WC, Leeuwen JP van, et al. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy Dutch children and young adults. Horm Res 2002;57(5-6):170-9.CrossRefPubMed Sluis IM van der, Hop WC, Leeuwen JP van, et al. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy Dutch children and young adults. Horm Res 2002;57(5-6):170-9.CrossRefPubMed
go back to reference Norman ME. Juvenile osteoporosis. In: Favus MJ (ed.). Primer on the metabolic bone disease and disorders of mineral metabolism. 3rd ed. Philadelphia: Lippincott-Raven; 1996. p. 275-8. Norman ME. Juvenile osteoporosis. In: Favus MJ (ed.). Primer on the metabolic bone disease and disorders of mineral metabolism. 3rd ed. Philadelphia: Lippincott-Raven; 1996. p. 275-8.
go back to reference Glorieux FH, Rauch F, Plotkin H, et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 2000;15:1650-8.CrossRefPubMed Glorieux FH, Rauch F, Plotkin H, et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 2000;15:1650-8.CrossRefPubMed
go back to reference Shaw NJ, Boivin CM, Crabtree NJ. Intravenous pamidronate in juvenile osteoporosis. Arch Dis Child 2000;83:143-5.CrossRefPubMed Shaw NJ, Boivin CM, Crabtree NJ. Intravenous pamidronate in juvenile osteoporosis. Arch Dis Child 2000;83:143-5.CrossRefPubMed
go back to reference Plotkin H, Rauch F, Bishop NJ, et al. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 2000;85:1846-50.CrossRefPubMed Plotkin H, Rauch F, Bishop NJ, et al. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 2000;85:1846-50.CrossRefPubMed
go back to reference Sluis IM van der, Boot AM, Hop WC, et al. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: 6 years follow-up. Horm Res 2002;58:207-14.CrossRefPubMed Sluis IM van der, Boot AM, Hop WC, et al. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: 6 years follow-up. Horm Res 2002;58:207-14.CrossRefPubMed
go back to reference Lucidarme N, Ruiz JC, Czernichow P, et al. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves’ disease. J Pediatr 2000; 137:56-62.CrossRefPubMed Lucidarme N, Ruiz JC, Czernichow P, et al. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves’ disease. J Pediatr 2000; 137:56-62.CrossRefPubMed
go back to reference Young N, Formica C, Szmukler G, et al. Bone density at weight-bearing and nonweight-bearing sites in ballet dansers: effects of exercise, hypogonadism, and body weight. J Clin Endocrinol Metab 1994;78:449-54.CrossRefPubMed Young N, Formica C, Szmukler G, et al. Bone density at weight-bearing and nonweight-bearing sites in ballet dansers: effects of exercise, hypogonadism, and body weight. J Clin Endocrinol Metab 1994;78:449-54.CrossRefPubMed
go back to reference Grinspoon S, Miller K, Coyle C, et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 1999;84:2049-55.CrossRefPubMed Grinspoon S, Miller K, Coyle C, et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 1999;84:2049-55.CrossRefPubMed
go back to reference Bachrach LK, Katzman DK, Litt IF, et al. Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 1991;72:602-6.CrossRefPubMed Bachrach LK, Katzman DK, Litt IF, et al. Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 1991;72:602-6.CrossRefPubMed
go back to reference Finkelstein JS, Neer RM, Biller BMK, et al. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992;326:600-4.PubMedCrossRef Finkelstein JS, Neer RM, Biller BMK, et al. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992;326:600-4.PubMedCrossRef
go back to reference Bertelloni S, Baroncelli GI, Ferdeghini M, et al. Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty. J Clin Endocrinol Metab 1998;83(12):4280-3.CrossRefPubMed Bertelloni S, Baroncelli GI, Ferdeghini M, et al. Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty. J Clin Endocrinol Metab 1998;83(12):4280-3.CrossRefPubMed
go back to reference Infante D, Tormo R. Risk of inadequate bone mineralization in diseases involving long-term suppression of dairy products. J Pediatr Gastroenterol Nutr 2000;30:310-3.CrossRefPubMed Infante D, Tormo R. Risk of inadequate bone mineralization in diseases involving long-term suppression of dairy products. J Pediatr Gastroenterol Nutr 2000;30:310-3.CrossRefPubMed
go back to reference Bonjour JP, Schurch MA, Chevalley T, et al. Protein intake, IGF-1 and osteoporosis. Osteoporos Int 1997;7(suppl 3):S36-42.PubMed Bonjour JP, Schurch MA, Chevalley T, et al. Protein intake, IGF-1 and osteoporosis. Osteoporos Int 1997;7(suppl 3):S36-42.PubMed
go back to reference Bianchi ML. Glucocorticoids and bone: Some general remarks and some special observations in pediatric patients. Calcif Tissue Int 2002;70:384-90.CrossRefPubMed Bianchi ML. Glucocorticoids and bone: Some general remarks and some special observations in pediatric patients. Calcif Tissue Int 2002;70:384-90.CrossRefPubMed
go back to reference Sluis IM van der, Heuvel MM van den, Hahlen K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002;141:204-10.CrossRefPubMed Sluis IM van der, Heuvel MM van den, Hahlen K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002;141:204-10.CrossRefPubMed
go back to reference Sluis IM van der, Heuvel-Eibrink MM van den, Hahlen K, et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 2000;35:415-20.CrossRefPubMed Sluis IM van der, Heuvel-Eibrink MM van den, Hahlen K, et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 2000;35:415-20.CrossRefPubMed
go back to reference Kwaliteitsinstituut van de Gezondheidszorg CBO. Osteoporose: Tweede Herziene Richtlijn. Utrecht: CBO; 2002. Kwaliteitsinstituut van de Gezondheidszorg CBO. Osteoporose: Tweede Herziene Richtlijn. Utrecht: CBO; 2002.
go back to reference Touati G, Prieur AM, Ruiz JC, et al. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and composition. J Clin Endocrinol Metabol 1998;83:403-9.CrossRef Touati G, Prieur AM, Ruiz JC, et al. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and composition. J Clin Endocrinol Metabol 1998;83:403-9.CrossRef
go back to reference Touati G, Ruiz JC, Porquet D, et al. Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy. J Rheumatol 2000;27:1287-93.PubMed Touati G, Ruiz JC, Porquet D, et al. Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy. J Rheumatol 2000;27:1287-93.PubMed
go back to reference Rooney M, Davies UM, Reeve J, et al. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis. J Rheumatol 2000; 27:1073-81.PubMed Rooney M, Davies UM, Reeve J, et al. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis. J Rheumatol 2000; 27:1073-81.PubMed
go back to reference Lepore L, Pennesi M, Barbi E, et al. Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate. Clin Exp Rheumatol 1991;9(suppl 6):33-5.PubMed Lepore L, Pennesi M, Barbi E, et al. Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate. Clin Exp Rheumatol 1991;9(suppl 6):33-5.PubMed
go back to reference Bianchi ML, Cimaz R, Bardare M, et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum 2000;43:1960-6.CrossRefPubMed Bianchi ML, Cimaz R, Bardare M, et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum 2000;43:1960-6.CrossRefPubMed
go back to reference Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.CrossRefPubMed Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.CrossRefPubMed
Metagegevens
Titel
Osteoporose op de kinderleeftijd
Auteurs
Dr. I. M. van der Sluis
Dr. S. M. P. F. de Muinck Keizer-Schrama
Publicatiedatum
01-12-2003
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Kindergeneeskunde / Uitgave 1/2003
Print ISSN: 0376-7442
Elektronisch ISSN: 1875-6840
DOI
https://doi.org/10.1007/BF03061468